Besides, considering that CD44 suppression and 5-FU treatment cooperatively inhibited CRC cell in vitro growth and migration, their combination could be regarded as a beneficial strategy to develop novel approaches for the improvement of CRC chemotherapy. This evidence concerns the gene CD44 and colorectal carcinoma.